Horien Biochemical Technology Co (ROCO:7814) ROC %: 18.94% (As of Dec. 2025)


ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$37.00
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co ROC %?

Horien Biochemical Technology Co ROCO:7814 21 ROC % is 18.94% as of Dec. 2025. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Horien Biochemical Technology Co's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was 18.94%.

As of today (2026-06-30), Horien Biochemical Technology Co's WACC % is 10.36%. Horien Biochemical Technology Co's ROC % is 7.38% (calculated using TTM income statement data). Horien Biochemical Technology Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Horien Biochemical Technology Co  (ROCO:7814) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Horien Biochemical Technology Co's WACC % is 10.36%. Horien Biochemical Technology Co's ROC % is 7.38% (calculated using TTM income statement data). Horien Biochemical Technology Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Horien Biochemical Technology Co ROC % Related Terms

Horien Biochemical Technology Co ROC % Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co ROC % Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROC %
3.54 16.38 20.76 -9.93

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
ROC % Get a 7-Day Free Trial 67.83 32.67 0.00 9.38 18.94
ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co ROC % Calculation

Horien Biochemical Technology Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-8.155 * ( 1 - 0% )/( (76.169 + 88.107)/ 2 )
=-8.155/82.138
=-9.93 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=330.148 - 23.541 - ( 230.438 - max(0, 29.294 - 263.819+230.438))
=76.169

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=320.253 - 22.553 - ( 209.593 - max(0, 26.076 - 249.991+209.593))
=88.107

Horien Biochemical Technology Co's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=16.712 * ( 1 - 0% )/( (88.399 + 88.107)/ 2 )
=16.712/88.253
=18.94 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=317.337 - 21.726 - ( 207.212 - max(0, 27.157 - 245.895+207.212))
=88.399

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=320.253 - 22.553 - ( 209.593 - max(0, 26.076 - 249.991+209.593))
=88.107

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 18.94% mean?
Horien Biochemical Technology Co (ROCO:7814) has a ROC % of 18.94% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Horien Biochemical Technology Co and its competitors.
Is Horien Biochemical Technology Co's ROC % too high?
Horien Biochemical Technology Co's current ROC % is 18.94%. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's ROC % compare to VRTX and REGN?
Horien Biochemical Technology Co's ROC % of 18.94% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current ROC % is 18.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current ROC % of 18.94%. The current ROC % is 18.94%. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current ROC % is 18.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$37.00
Price